Literature DB >> 28577220

Response to Sharma et al.: Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies.

Jaime Algorta1.   

Abstract

Year:  2017        PMID： 28577220     DOI： 10.1007/s40261-017-0535-y

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  7 in total

1.  Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies.

Authors:  Ashish Sharma; Benjamin Weber; Bernd Meibohm
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers.

Authors:  Stephen T Horhota; Jan A van Noord; Cynthia B Verkleij; Loek J Bour; Ashish Sharma; Michael Trunk; Piet J G Cornelissen
Journal:  AAPS J       Date:  2015-03-21       Impact factor: 4.009

Review 3.  Biochemical properties, pharmacokinetics and pharmacological response of tiotropium in chronic obstructive pulmonary disease patients.

Authors:  David Price; Ashish Sharma; Frank Cerasoli
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-04       Impact factor: 4.481

Review 4.  In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases.

Authors:  Sau Lawrence Lee; Wallace P Adams; Bing V Li; Dale P Conner; Badrul A Chowdhury; Lawrence X Yu
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

5.  Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers.

Authors:  Jaime Algorta; Laura Andrade; Marta Medina; Valentin Kirkov; Sacha Arsova; Fumin Li; Jingduan Chi
Journal:  Clin Drug Investig       Date:  2016-09       Impact factor: 2.859

6.  Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat® in Asthma Using Standardized Sample-Contamination Avoidance.

Authors:  Kai-Michael Beeh; Anne-Marie Kirsten; Daniel Dusser; Ashish Sharma; Piet Cornelissen; Ralf Sigmund; Petra Moroni-Zentgraf; Ronald Dahl
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-02-09       Impact factor: 2.849

7.  Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease.

Authors:  J M Hohlfeld; A Sharma; J A van Noord; P J G Cornelissen; E Derom; L Towse; V Peterkin; B Disse
Journal:  J Clin Pharmacol       Date:  2013-11-27       Impact factor: 3.126
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.